Under construction – not a live service
Sign in
Taking people in AustraliaNo phase

The National Australian HCV Point-of-Care Testing Program - Minimal Dataset

Key facts

Where
Aldershot, Brisbane, Cairns, Coorparoo, Fitzroy, Hackney, Ipswich, Marden, Melbourne, Mount Gambier, Rathdowney, Ravenhall, Sydney, Townsville, and Woodford, AustraliaSee the 16 sites

Where in Australia

  • Maryborough Correctional CentreAldershot, AustraliaContact: Ashley WillmanTaking people
  • QuIHNBrisbane, AustraliaContact: Nicholas AlexanderTaking people
  • Lotus Glen Correctional CentreCairns, AustraliaContact: Darren RussellTaking people
  • Hepatitis QueenslandCoorparoo, AustraliaContact: David Silk, BScNo longer taking part
  • St Vincent's Correctional Health ServicesFitzroy, AustraliaContact: David Silk, BScNo longer taking part
  • Hepatitis SAHackney, AustraliaContact: Lisa CarterTaking people
  • West Moreton Hospital and Health ServiceIpswich, AustraliaContact: Blake PontingTaking people
  • South Australian Prison Health ServiceMarden, AustraliaContact: Tom TurnbullNot yet recruiting
  • Medically Supervised Injecting RoomMelbourne, AustraliaContact: Nathan StamTaking people
  • Mount Gambier PriosnMount Gambier, AustraliaContact: William GallowayTaking people
  • Palen Creek Correctional CentreRathdowney, AustraliaContact: Mike HurleyNot yet recruiting
  • Dame Phyllis Frost CentreRavenhall, AustraliaContact: Katelyn MannixTaking people
  • Geo Healthcare - The Geo Group Australia Pty LtdRavenhall, AustraliaContact: David GraceTaking people
  • Justice Health and Forensic Mental Health NetworkSydney, AustraliaContact: David Silk, BScNo longer taking part
  • Townsville Correctional CentreTownsville, AustraliaContact: John MoreyTaking people
  • Woodford Correctional CentreWoodford, AustraliaContact: Rajendra PrakashTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Kirby Institute
Trial code
NCT05248555
Record updated
28 September 2026
Original description
The National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing services to people with a risk factor for the acquisition of HCV infection (including drug treatment clinics, needle and syringe programs, homelessness settings, mental health services, prisons, and mobile outreach). All participants who undergo HCV point-of-care testing at the study site will be included in the data collection. Participants will not receive treatment as a part of this study. Participants who are HCV RNA positive will be linked to standard of care.Read full original descriptionShow less

The National Australian HCV Point-of-Care Testing Program: An Observational Cohort Study to Evaluate the Use of Finger-stick Point-of-care Hepatitis C Testing to Enhance Diagnosis and Treatment of HCV Infection - Minimal Dataset

The National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing services to people with a risk factor for the acquisition of HCV infection (including drug treatment clinics, needle and syringe programs, homelessness settings, mental health services, prisons, and mobile outreach). All participants who undergo HCV point-of-care testing at the study site will be included in the data collection. Participants will not receive treatment as a part of this study. Participants who are HCV RNA positive will be linked to standard of care.

Inclusion: ≥ 18 years of age; Received point-of-care HCV testing.

Exclusion: Nil.

ClinicalTrials.gov NCT05248555